Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of XP12B in Women With Menorrhagia

ClinicalTrials.gov ID: NCT00386308

Public ClinicalTrials.gov record NCT00386308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia

Study identification

NCT ID
NCT00386308
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
196 participants

Conditions and interventions

Interventions

  • Tranexamic acid tablets Drug
  • Placebo tablets Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Apr 30, 2008
Completion
Apr 30, 2008
Last update posted
May 3, 2011

2006 – 2008

United States locations

U.S. sites
52
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Investigative Site Tucson Arizona 85712
Investigative Site Tucson Arizona 85741
Investigative Site Little Rock Arkansas 72205
Investigative Site Carmichael California 95608
Investigative Site San Diego California 92123
Investigative Site Upland California 91786
Investigative Site Denver Colorado 80206
Investigative Site Lakewood Colorado 80228
Investigative Site Groton Connecticut 06340
Investigative Site West Hartford Connecticut 06117
Investigative Site Inverness Florida 34452
Investigative Site Miami Florida 33133
Investigative Site Miami Florida 33136
Investigative Site Atlanta Georgia 30328
Investigative Site Atlanta Georgia 30342
Investigative Site Decatur Georgia 30033
Investigative Site Savannah Georgia 31406
Investigative Site Idaho Falls Idaho 83404
Investigative Site Amite Louisiana 70422
Investigative Site Baton Rouge Louisiana 70808
Investigative Site Marrero Louisiana 70072
Investigative Site Shreveport Louisiana 71115
Investigative Site Paw Paw Michigan 49079
Investigative Site Scottsbluff Nebraska 69361
Investigative Site Lawrenceville New Jersey 08648
Investigative Site Canfield Ohio 44406
Investigative Site Centerville Ohio 45459
Investigative Site Cleveland Ohio 44122
Investigative Site Zanesville Ohio 43701
Investigative Site Norman Oklahoma 73071
Investigative Site Oklahoma City Oklahoma 73112
Investigative Site Eugene Oregon 97401
Investigative Site Medford Oregon 97504
Investigative Site Portland Oregon 97210
Investigative Site Salem Oregon 97301
Investigative Site Abington Pennsylvania 19001
Investigative Site Jenkintown Pennsylvania 19046
Investigative Site Reading Pennsylvania 19606
Investigative Site Charleston South Carolina 29401
Investigative Site Columbia South Carolina 29201
Investigative Site Greenville South Carolina 29615
Investigative Site Greer South Carolina 29651
Investigative Site Chattanooga Tennessee 37403
Investigative Site Knoxville Tennessee 37920
Investigative Site Memphis Tennessee 38119
Investigative Site Dallas Texas 75235
Investigative Site Houston Texas 77030
Investigative Site Sandy City Utah 84070
Investigative Site Spokane Washington 99207
Investigative Site Charleston West Virginia 25301
Investigative Site Huntington West Virginia 25701
Investigative Site Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00386308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00386308 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →